4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-039770
Director acquired 3,300 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sanders Corazon (Corsee) D. Director | 2022-06-24 | Grant or award | +3,300 | 7,195 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sanders Corazon (Corsee) D. Director | 2022-06-24 | Grant or award · Stock Option (Right to Buy) | +6,245 | 6,245 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…